Oncology focused biotechnology company, Exelixis has announced that USFDA has approved CABOMETYX tablets for patients wi...
AstraZeneca has announced that the European Commission (EC) has approved Bevespi Aerosphere (glycopyrronium/formote...
The U.S. Food and Drug Administration has approved VAXELIS™ (Diphtheria and Tetanus Toxoids and Acellular Pertussi...
U.S. based Kronos Bio has announced that it has appointed Philip Gutry as its Chief Business Officer. In this newly cre...
Singapore - Esco Aster (Singapore) and Nuvonis Technologies (Austria) will sign a Memorandum of Understanding (MoU) for ...
Singapore - Enesi Pharma, an innovative pharmaceutical company developing unique injectable solid dosevac...
Pharma giant GSK and Aeras reported that GSK’s candidate vaccine significantly reduced the incidence of pulmonary ...
PATH welcomes the World Health Organization's (WHO's) prequalification of the thermostable rotavirus vaccine, ROTASIIL, ...
Inovio Pharmaceuticals and Korea's GeneOne Life Science have announced that they have dosed the first patient in a Phase...
India, once called as the vaccine capital, is slowly losing its sheen because of various reasons, primarily the aggressi...
China Food and Drug Administration (CFDA) has issued an announcement asking Changchun Changsheng Life Sciences, China&rs...
Singapore – Esco Aster, a leading independent contract development and manufacturing organization with its patent ...
Merck, known as MSD outside the United States and Canada, has announced that the US Food and Drug Administration (FDA) h...
On HIV Vaccine Awareness Day, 18 May, UNAIDS is calling for an increase in research and investment to find an effective ...
Researchers, doctors and patients have teamed with Lung Foundation Australia during this week’s Pneumonia Awa...
The first vaccine campaign against cholera in Yemen has been started by the World Health Organization (WHO), a year and ...
Sinovac Biotech, a leading provider of biopharmaceutical products in China, has announced preliminary results of a phase...
Oxford Vacmedix UK Limited (OVM), a UK-based biopharma company and a spin out of Oxford University Innovation, is commer...
